Terms: = Liver cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Staging
95 results:
1. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
[No Abstract] [Full Text] [Related]
2. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
Liu J; Zhu X; Pan Y; Zhong J; Jin R; Zheng X; Zhang W; Hu K; Ma J; Shi X; Liu H; Yang X; Xu D; Ma C; Chen J; Wang D; Wang X; Li Z; Zhao L; Zhang L; Li T; Liu F; Tan G; Xing B; Zhao H; Zeng Y; Zhang S; Zhang L; Zhou L; Song T; Yang W; Liang X; Xiang B; Xu L; Sun H; Wang K
Oncologist; 2024 Apr; 29(4):e487-e497. PubMed ID: 37874924
[TBL] [Abstract] [Full Text] [Related]
3. The Role of staging Laparoscopy for Intrahepatic Cholangiocarcinoma: A Snapshot of the Current Literature.
Coletta D; Scarinci A; Grazi GL; Patriti A
J Laparoendosc Adv Surg Tech A; 2023 Nov; 33(11):1019-1024. PubMed ID: 37768853
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study.
Huang J; Wang ZG; Tao QF; Yang Y; Yuan SX; Gu FM; Liu H; Pan ZY; Jiang BG; Lau WY; Zhou WP
Front Immunol; 2023; 14():1198562. PubMed ID: 37483609
[TBL] [Abstract] [Full Text] [Related]
5. Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy.
Wu JL; Luo JY; Jiang ZB; Huang SB; Chen GR; Ran HY; Liang QY; Huang MS; Lai LS; Chen JW
World J Gastroenterol; 2023 May; 29(20):3168-3184. PubMed ID: 37346152
[TBL] [Abstract] [Full Text] [Related]
6. Detection of met gene somatic mutations in hepatocellular carcinoma of Egyptian patients using next-generation sequencing.
Ahmed E; El-Dien A N; Sabet S; Khalifa M; El Hamshary M
Biomarkers; 2023 Jun; 28(4):379-386. PubMed ID: 36825430
[TBL] [Abstract] [Full Text] [Related]
7. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
[TBL] [Abstract] [Full Text] [Related]
8. Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma.
Xu S; Zhang XP; Zhao GD; Zou WB; Zhao ZM; Liu Q; Hu MG; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):160-168. PubMed ID: 36171167
[TBL] [Abstract] [Full Text] [Related]
9. A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: A multicenter study.
Zhang XP; Gao YX; Xu S; Zhao GD; Hu MG; Tan XL; Zhao ZM; Liu R
Int J Surg; 2022 Oct; 106():106891. PubMed ID: 36165934
[TBL] [Abstract] [Full Text] [Related]
10. Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus.
Maharaj AD; Lubel J; Lam E; Clark PJ; Duncan O; George J; Jeffrey GP; Lipton L; Liu H; McCaughan G; Neo EL; Philip J; Strasser SI; Stuart K; Thompson A; Tibballs J; Tu T; Wallace MC; Wigg A; Wood M; Zekry A; Greenhill E; Ioannou LJ; Ahlenstiel G; Bowers K; Clarke SJ; Dev A; Fink M; Goodwin M; Karapetis CS; Levy MT; Muller K; O'Beirne J; Pryor D; Seow J; Shackel N; Tallis C; Butler N; Olynyk JK; Reed-Cox K; Zalcberg JR; Roberts SK
Hepatol Commun; 2022 Nov; 6(11):3260-3271. PubMed ID: 36153817
[TBL] [Abstract] [Full Text] [Related]
11. Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review.
Alonso JC; Casans I; González FM; Fuster D; Rodríguez A; Sánchez N; Oyagüez I; Burgos R; Williams AO; Espinoza N
BMC Gastroenterol; 2022 Jul; 22(1):326. PubMed ID: 35780112
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic performance of [
Mirshahvalad SA; Hinzpeter R; Kohan A; Anconina R; Kulanthaivelu R; Ortega C; Metser U; Veit-Haibach P
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4205-4217. PubMed ID: 35705874
[TBL] [Abstract] [Full Text] [Related]
13. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
[TBL] [Abstract] [Full Text] [Related]
14. Hepatocellular carcinoma - prognostic criteria of individualized treatment.
Kysela P; Kala Z; Zatloukal M; Raudenská M; Brančíková D
Klin Onkol; 2022; 35(2):100-113. PubMed ID: 35459334
[TBL] [Abstract] [Full Text] [Related]
15. Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients.
Ding DY; Liu L; Li HL; Gan XJ; Ding WB; Gu FM; Sun DP; Li W; Pan ZY; Yuan SX; Zhou WP
Hepatobiliary Pancreat Dis Int; 2023 Feb; 22(1):72-80. PubMed ID: 35428596
[TBL] [Abstract] [Full Text] [Related]
16. Identification and Validation of the Prognostic Impact of metastatic Prostate cancer Phenotypes.
Labe SA; Wang X; Lehrer EJ; Kishan AU; Spratt DE; Lin C; Morgans AK; Ponsky L; Garcia JA; Garrett S; Wang M; Zaorsky NG
Clin Genitourin Cancer; 2022 Aug; 20(4):371-380. PubMed ID: 35383004
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritonei.
Flood MP; Kong JC; Pham T; Waters PS; Soucisse M; Ramsay R; Wong HL; Mitchell C; Michael M; McCormick JJ; Warrier SK; Akhurst T; Heriot AG
Eur J Surg Oncol; 2022 Jul; 48(7):1606-1613. PubMed ID: 35148916
[TBL] [Abstract] [Full Text] [Related]
18. Structured CT reporting of pancreatic ductal adenocarcinoma: impact on completeness of information and interdisciplinary communication for surgical planning.
Malik RF; Hasanain A; Lafaro KJ; He J; Narang AK; Fishman EK; Zaheer A
Abdom Radiol (NY); 2022 Feb; 47(2):704-714. PubMed ID: 34800162
[TBL] [Abstract] [Full Text] [Related]
19.
Mittlmeier LM; Todica A; Gildehaus FJ; Unterrainer M; Beyer L; Brendel M; Albert NL; Ledderose ST; Vettermann FJ; Schott M; Rodler S; Marcon J; Ilhan H; Cyran CC; Stief CG; Staehler M; Bartenstein P
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1711-1720. PubMed ID: 34708249
[TBL] [Abstract] [Full Text] [Related]
20. The management of post-transplantation recurrence of hepatocellular carcinoma.
Rajendran L; Ivanics T; Claasen MP; Muaddi H; Sapisochin G
Clin Mol Hepatol; 2022 Jan; 28(1):1-16. PubMed ID: 34610652
[TBL] [Abstract] [Full Text] [Related]
[Next]